European countries are falling short on fight against HIV, TB and STIs, health authorities warn
Europe will miss its targets to combat HIV,
tuberculosis (TB)
, hepatitis, and sexually transmitted infections (STIs) without significant investments in public health, regional health authorities have warned.
These four diseases cause nearly 57,000 deaths every year in the European Union, Iceland, Liechtenstein, and Norway,
according to the new report
from the European Centre for Disease Prevention and Control (ECDC).
But many countries are not on track to meet official goals to eliminate infectious disease epidemics by 2030, and the region has not met most of these targets for 2025.
Related
Health authorities push for 'urgent' action as some STIs reach new highs in Europe
"These diseases are preventable, as is the burden they place on health systems, patients, and their families," ECDC Director Pamela Rendi-Wagner said in a statement.
Some progress has been made. The number of new
HIV infections
has fallen by 35 per cent since 2010, and TB incidence has decreased by 35 per cent since 2015 – though the region's goals were a respective 75 per cent and 50 per cent reduction by 2025.
STIs reaching record levels
The number of deaths from AIDS-related causes has fallen by 30 per cent since 2010, with 3,300 deaths in 2023. But health officials had wanted to cut that figure in half.
Deaths from hepatitis B and C remain high, and cases of acute hepatitis B are rising. The infections spread through sexual contact or when drug users share contaminated syringes, and can cause cirrhosis and liver cancer.
Meanwhile, rates of STIs such as syphilis and gonorrhoea are
reaching record levels
.
Authorities now detect almost all new and relapsed TB cases, but drug resistance and treatment remain challenging. In 2022, just 68 per cent of people who started TB treatment actually completed it, falling short of the region's 90 per cent target.
Related
Why is tuberculosis, the world's deadliest infectious disease, on the rise in the UK?
The ECDC called for additional efforts to prevent these diseases, for example improving uptake of pre-exposure prophylaxis (PrEP) to help prevent HIV infection, increasing vaccinations for hepatitis B, and getting people to use
condoms
.
The agency also wants countries to expand testing services to try to detect infections earlier on, shore up data collection, and take steps to help people with diseases like TB – for which they must take daily pills for four to nine months – stay on their treatment.
"We have five years to act; we must make them count," Rendi-Wagner said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Euronews
3 days ago
- Euronews
European beachgoers face risks from sea bacteria as summer heats up
As holiday-goers flock to Europe's beaches this summer, health authorities are warning about the growing health risks from bacteria that thrive in warm, brackish water. The European Centre for Disease Prevention and Control (ECDC) issued an alert over Vibrio bacteria, which are often found in the Baltic Sea but are now appearing across Europe as sea temperatures rise. 'The bacteria live naturally in brackish coastal waters, where saltwater and freshwater mix, especially when temperatures are high and salinity is lower,' the ECDC said. 'These conditions are becoming increasingly common in parts of Europe due to climate change,' the agency added, noting that the bacteria has been found in the North Sea and enclosed bathing sites. Vibrio bacterial infections, called vibriosis, can cause serious health issues. People can be infected by eating raw or undercooked shellfish, particularly oysters, or by swimming in bacteria-heavy waters while they have a cut or another open wound. People with weakened immune systems or chronic liver conditions are at higher risk from complications such as sepsis, bloodstream infections, flesh-eating disease or even limb amputation. These infections are still 'relatively rare' in Europe, the ECDC said. But several northern countries around the Baltic Sea have reported an increase in cases in recent years, particularly in summers with longer heatwaves. In 2018, for example, 445 cases were reported during one of Europe's hottest summers on record. That's more than triple the median of 126 cases recorded per year between 2014 and 2017. But that is likely an undercount because infections are 'probably under-reported,' the agency said. The ECDC recommends that people avoid eating raw shellfish and ensure their seafood is cooked thoroughly. It also said people with cuts or recent piercings should avoid swimming in brackish or salty water or cover their cuts with waterproof bandages. The agency advised people to 'be aware of the risks and to consult a doctor if symptoms appear after contact with the type of water where Vibrio bacteria thrive'.
Euronews
5 days ago
- Euronews
Millions will die if US funding to fight HIV is not replaced, UN warns
The US's decision to halt most foreign aid this year has been a 'systemic shock' to the fight against AIDS, according to officials from the United Nations who said there could be more than four million AIDS-related deaths and six million more HIV infections by 2029 if the US funding is not replaced. Years of US-led investment into AIDS programmes has reduced the number of people killed by the disease to the lowest levels seen in more than three decades, and provided life-saving medicines for some of the world's most vulnerable. But in the last six months, the sudden withdrawal of US money has threatened that progress, UNAIDS said in a report released Thursday. 'The current wave of funding losses has already destabilised supply chains, led to the closure of health facilities, left thousands of health clinics without staff, set back prevention programmes, disrupted HIV testing efforts, and forced many community organisations to reduce or halt their HIV activities,' the agency said. UNAIDS also said that it feared other major donors might also scale back their support, reversing decades of progress against AIDS worldwide – and that the strong multilateral cooperation is in jeopardy because of wars, geopolitical shifts, and climate change. The $4 billion (€3.4 billion) that the US pledged for the global HIV response for 2025 disappeared virtually overnight in January when US President Donald Trump ordered that all foreign aid be suspended and later moved to shutter the US aid agency. Andrew Hill, an HIV expert at the University of Liverpool who is not connected to the UN, said that while Trump is entitled to spend US money as he sees fit, 'any responsible government would have given advance warning so countries could plan,' instead of stranding patients in Africa when clinics were closed overnight. Impact of US investment in HIV/AIDS The US President's Emergency Plan for AIDS Relief, or PEPFAR, was launched in 2003 by then-President George W Bush, the biggest-ever commitment by any country focused on a single disease. UNAIDS called the programme a 'lifeline' for countries with high HIV rates, and said that it supported testing for 84.1 million people, treatment for 20.6 million, among other initiatives. According to data from Nigeria, PEPFAR also funded 99.9 per cent of the country's budget for medicines taken to prevent HIV. In 2024, there were about 630,000 AIDS-related deaths worldwide, per a UNAIDS estimate. That figure has remained about the same since 2022, after peaking at about two million deaths in 2004. Even before the US funding cuts, progress against curbing HIV was uneven. UNAIDS said that half of all new infections are in sub-Saharan Africa and that more than 50 per cent of all people who need treatment but aren't getting it are in Africa and Asia. 'US is abandoning the fight' The political uncertainty arrived shortly after a medical breakthrough in the fight against HIV. Studies published last year showed that a twice-yearly injectable drug from pharmaceutical maker Gilead was 100 per cent effective in preventing the virus. Last month, the US Food and Drug Administration (FDA) approved the drug, called Sunleca – a move that should have been a 'threshold moment' for stopping the AIDS epidemic, said Peter Maybarduk of the advocacy group Public Citizen. But activists like Maybarduk said Gilead's pricing will put it out of reach of many countries that need it. Gilead has agreed to sell generic versions of the drug in 120 poor countries with high HIV rates but has excluded nearly all of Latin America, where rates are far lower but increasing. 'We could be ending AIDS," Maybarduk said. 'Instead, the US is abandoning the fight'.
France 24
5 days ago
- France 24
US funding cuts could reverse decades of gains in AIDS fight: UN
Around 31.6 million people were on antiretroviral drugs in 2024 and deaths from AIDS-related illnesses had more than halved since 2010 to 630,000 that year, the UNAIDS agency said in a new report. But now infections were likely to shoot up as funding cuts have shuttered prevention and treatment programmes, it said. The United States has been the world's biggest donor of humanitarian assistance but President Donald Trump's abrupt slashing of international aid in February sent the global humanitarian community scrambling to keep life-saving operations afloat. "We are proud of the achievements, but worried about this sudden disruption reversing the gains we have made," UNAIDS executive director Winnie Byanyima told AFP ahead of the report's launch in Johannesburg. The agency in April warned that a permanent discontinuation of PEPFAR, the massive US effort to fight HIV/AIDS, would lead to more than six million new infections and an additional 4.2 million AIDS-related deaths in the next four years. This would bring the pandemic back to levels not seen since the early 2000s. "This is not just a funding gap – it's a ticking time bomb" whose effects are already felt worldwide, Byanyima said in a press release. Over 60 percent of all women-led HIV organisations surveyed by UNAIDS had lost funding or had to suspend services, the report said. In a striking example, the number of people receiving pre-exposure prophylaxis (PrEP) drugs to prevent transmission in Nigeria fell by over 85 percent in the first few months of 2025. The "story of how the world has come together" to fight HIV/AIDS is "one of the most important stories of progress in global health," Byanyima told AFP. "But that great story has been disrupted massively" by Trump's "unprecedented" and "cruel" move, she said. "Priorities can shift, but you do not take away life-saving support from people just like that," she said. Key medical research affected Crucial medical research on prevention and treatment have also shut down, including many in South Africa which has one of the highest HIV rates in the world and has become a leader in global research. "Developing countries themselves contribute very much towards the research on HIV and AIDS, and that research serves the whole world," Byaniyma said. In 25 out of 60 low- and middle-income countries surveyed by UNAIDS, governments had found ways to compensate part of the funding shortfall with domestic resources. "We have to move towards nationally-owned and financed responses," Byaniyma said, calling for debt relief and the reform of international financial institutions to "free up the fiscal space for developing countries to pay for their own response". Still, the global HIV response built from grassroots activism was "resilient by its very nature", she told AFP. "We moved from people dying every single day to now a point where it is really like a chronic illness," she said. © 2025 AFP
